Evercore ISI initiates Accenture stock with Outperform rating on AI potential

Published 17/07/2025, 11:50
© Reuters

Investing.com - Evercore ISI initiated coverage on Accenture plc (NYSE:ACN) with an Outperform rating and a $330.00 price target on Thursday. According to InvestingPro data, the stock is currently trading near its 52-week low, with analysts setting targets ranging from $263 to $395.

The research firm cited Accenture’s strong positioning to help enterprises navigate the complexities of the current AI-led technology transition over the medium term. Evercore ISI views the year-to-date stock underperformance of -19.37% as a buying opportunity, particularly as clarity emerges around macroeconomic conditions and DOGE initiatives. InvestingPro analysis shows the company maintains a GOOD overall financial health score, suggesting robust fundamentals despite market volatility.

Evercore ISI projects Accenture can achieve "$16+ medium-term EPS upside" by sustaining mid to high single-digit sales growth, 30-50 basis points of annual margin expansion, and double-digit EPS/FCF growth over the next several years. The firm expects AI to spur multi-year tailwinds for Accenture, similar to the uplift the company experienced during the initial proliferation of public cloud in the FY13-FY23 timeframe.

The research note highlighted Accenture’s market leadership, scale, and breadth of capabilities as factors positioning the company for continued market and IT spend outperformance. Evercore ISI also pointed to Accenture’s strong free cash flow conversion of approximately 130% of net income, which enables value-adding M&A strategies.

On valuation, Evercore ISI noted that Accenture is currently trading at a discount to its historical average, suggesting potential for multiple expansion toward the mean, supporting the $330 price target. The stock currently trades at a P/E ratio of 22.01, and InvestingPro analysis indicates additional valuable insights are available in the comprehensive Pro Research Report, which provides deep-dive analysis of Accenture’s financial health, valuation metrics, and growth prospects.

In other recent news, Accenture has been active with several notable developments. The company is set to report its fiscal fourth-quarter results in late September, which will include financial guidance for fiscal year 2026. UBS reiterated its Buy rating on Accenture following the acquisition of SYSTEMA, a German software solutions provider, enhancing Accenture’s capabilities in manufacturing automation. Meanwhile, TD Cowen adjusted its price target for Accenture to $342 from $347, maintaining a Buy rating despite noting light bookings and challenges in the Digital, Operations, Growth, and Enablement segment.

Accenture has also formed a strategic partnership with Palantir Technologies (NASDAQ:PLTR), where Accenture Federal Services will deploy AI-powered solutions for U.S. federal government customers. Stifel reiterated its Buy rating on Accenture, emphasizing the company’s strong management and potential upside to fiscal year 2026 estimates. UBS expressed confidence in Accenture’s ability to achieve 6-7% revenue growth, citing generative AI as a growth catalyst with bookings reaching $1.5 billion in the fiscal third quarter. These recent developments highlight Accenture’s ongoing strategic initiatives and market activities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.